BALAXI PHARMACEUTICALS: The financial results for the period ended September 30, 2026
BALAXI PHARMACEUTICALS (BALAXI) filed a disclosure titled "The financial results for the period ended September 30, 2026". The company is valued at about ₹135 crore.
What happened
BALAXI PHARMACEUTICALS (BALAXI) filed a disclosure with the exchanges on 12 November 2026 at 01:58 PM titled "The financial results for the period ended September 30, 2026".
Company snapshot
BALAXI PHARMACEUTICALS is a micro-cap company, with a market value of about ₹135 crore.
The stock last traded at ₹24.51, against a 52-week range of ₹15.2–₹40.98 (40.2% below the high).
Before this filing the shares had moved +1.5% over the month and −6.3% over three months. Average daily turnover over the last 20 sessions was about ₹0.04 crore.
Promoters held 65.99% at the end of Q1 FY27. Foreign institutions owned 0.00% and domestic institutions 2.56%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 71 | 0.3 | 0.05 |
| Q2 FY26 | 56 | 0.2 | 0.04 |
| Q3 FY26 | 73 | 0.3 | 0.06 |
| Q4 FY26 | 71 | 0.6 | 0.11 |
| Q1 FY27 | 81 | 1.3 | 0.24 |
What history shows
This is not the company's first results disclosure: BCEIE has 2 earlier filings of this kind on record since May 2026.
After those filings, the stock gained 2.4% on average the next trading day and was down 1.3% on average after five days (2 filings with price data).
Market-wide, 11,631 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 43% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 5 Aug 2026 | , the financial results for the quarter ended 30th June, 2026. | +0.7% | +0.1% |
| 28 May 2026 | , the financial results for the period ended March 31, 2026. | +4.2% | −2.8% |
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
- 12 November 2026: Board meeting — Financial Results/Other business matters.
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.